140 related articles for article (PubMed ID: 30417685)
21. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Biomarkers for Risk Assessment of Particulate Matter Associated Lung Cancer.
Bhargava A; Bunkar N; Aglawe A; Pandey KC; Tiwari R; Chaudhury K; Goryacheva IY; Mishra PK
Curr Drug Targets; 2018; 19(10):1127-1147. PubMed ID: 28891455
[TBL] [Abstract][Full Text] [Related]
24. Individual and joint contributions of genetic and methylation risk scores for enhancing lung cancer risk stratification: data from a population-based cohort in Germany.
Yu H; Raut JR; Schöttker B; Holleczek B; Zhang Y; Brenner H
Clin Epigenetics; 2020 Jun; 12(1):89. PubMed ID: 32552915
[TBL] [Abstract][Full Text] [Related]
25. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
26. Chromosomal numerical aberrations in apparently normal oral mucosa of heavy smokers affected by lung cancer.
Shani T; Onn A; Kabha A; Ben-Dov I; Adam I; Amariglio N; Yahalom R; Rechavi G; Trakhtenbrot L; Hirshberg A
Oral Oncol; 2010 Feb; 46(2):96-9. PubMed ID: 20004132
[TBL] [Abstract][Full Text] [Related]
27. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood.
Tan S; Sun C; Wei X; Li Y; Wu Y; Yan Z; Feng F; Wang J; Wu Y
Exp Lung Res; 2013; 39(4-5):182-90. PubMed ID: 23614702
[TBL] [Abstract][Full Text] [Related]
28. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status.
Kim H; Yang JM; Jin Y; Jheon S; Kim K; Lee CT; Chung JH; Paik JH
Oncotarget; 2017 Jan; 8(5):8484-8498. PubMed ID: 28035073
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR.
Ostrow KL; Hoque MO; Loyo M; Brait M; Greenberg A; Siegfried JM; Grandis JR; Gaither Davis A; Bigbee WL; Rom W; Sidransky D
Clin Cancer Res; 2010 Jul; 16(13):3463-72. PubMed ID: 20592015
[TBL] [Abstract][Full Text] [Related]
31. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
[No Abstract] [Full Text] [Related]
32. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH
J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197
[TBL] [Abstract][Full Text] [Related]
33. Absolute quantification of DNA methylation using microfluidic chip-based digital PCR.
Wu Z; Bai Y; Cheng Z; Liu F; Wang P; Yang D; Li G; Jin Q; Mao H; Zhao J
Biosens Bioelectron; 2017 Oct; 96():339-344. PubMed ID: 28525852
[TBL] [Abstract][Full Text] [Related]
34. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
[TBL] [Abstract][Full Text] [Related]
35. High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes.
Abe M; Yamashita S; Mori Y; Abe T; Saijo H; Hoshi K; Ushijima T; Takato T
BMC Cancer; 2016 Jun; 16():350. PubMed ID: 27255271
[TBL] [Abstract][Full Text] [Related]
36. Methylated DLX4 Predicts Response to Pathologic Stage I Non-Small Cell Lung Cancer Resection.
Harada H; Miyamoto K; Yamashita Y; Taniyama K; Ohdan H; Okada M
Ann Thorac Surg; 2015 May; 99(5):1746-54. PubMed ID: 25825198
[TBL] [Abstract][Full Text] [Related]
37. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
38. Oral mucosa and lung cancer: Are genetic changes in the oral epithelium associated with lung cancer?
Kömerik N; Yüce E; Calapoğlu NS; Koşar PA; Çakir M; Koparan G
Niger J Clin Pract; 2017 Jan; 20(1):12-18. PubMed ID: 27958240
[TBL] [Abstract][Full Text] [Related]
39. Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer.
Woodson K; Mason J; Choi SW; Hartman T; Tangrea J; Virtamo J; Taylor PR; Albanes D
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):69-74. PubMed ID: 11205492
[TBL] [Abstract][Full Text] [Related]
40. Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection.
AEGIS Study Team
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
